SCOTT FEATHERSTON
Chief Financial Officer
An extensive experience investing in growth and early-stage companies in health sector, particularly in emerging markets and also has interests in education.
BEN TALBOT
Clinical Advisor
A British doctor who has trained in renal medicine in Australia and the UK and is completing a PhD at the George Institute focused on improving the outcomes and economics of treating chronic kidney disease globally.